Granocyte 33.6 Mio (Lenograstim Vials) 33.6 Mio

Granocyte 33.6 Mio is a prescription medication containing lenograstim, a granulocyte colony-stimulating factor (G-CSF). It supports white blood cell production in patients undergoing chemotherapy or stem cell therapy. This vial form is designed for subcutaneous or intravenous use. Store at ambient temperature for convenience.

Strength

33.6 Mio

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Sanofi-Aventis Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lenograstim is primarily used to reduce the duration of severe neutropenia in patients receiving chemotherapy for certain cancers. It may also help mobilize stem cells for collection before transplant procedures. Some patients with severe chronic neutropenia use it long-term to maintain healthy white blood cell levels. It is not a general immune booster or a treatment for infections.

Side Effects

Common effects include mild to moderate bone pain, which may occur as bone marrow activity increases. Some users report temporary headaches or fatigue shortly after administration. These effects are usually short-lived and resolve without intervention. Injection site reactions like redness or swelling may also appear but are generally mild.

Precautions & Warnings

Keep vials away from children and pets, and store them in a secure, dry place at room temperature. Avoid exposure to extreme heat or direct sunlight. If the solution appears discolored or contains particles, do not use it. Always follow healthcare provider instructions for handling and disposal of medical waste.

Avoid Interactions

Lenograstim may interact with other medications that affect bone marrow function, such as certain chemotherapy drugs. Combining it with lithium could theoretically enhance its effects, though this is not well-documented. No major food or alcohol interactions are known, but always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

Lenograstim is used to stimulate white blood cell production in patients undergoing chemotherapy or stem cell therapy.

It is typically given as an injection under the skin or into a vein, as directed by a healthcare professional.

This medication requires a prescription and is not available for over-the-counter purchase.

Common side effects include bone pain, headaches, and mild injection site reactions.

Store the vials at room temperature, away from heat and direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.